January 22, 2015—The Food and Drug Administration approved 41 “novel new” drugs in 2014, of which 17 – a record high – were for orphan diseases or conditions, the federal agency says in a new report.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)